Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-02-22

Clinical Trial Update: Antioxidant Supplementation in Patients With Kashin-Beck Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on antioxidant supplementation for Kashin-Beck Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Innovative Humanitarian Solutions | Conditions: Kashin-Beck Disease | Phase 2 | Status: UNKNOWN